{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T13:38:23Z","timestamp":1772804303875,"version":"3.50.1"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,2,18]],"date-time":"2022-02-18T00:00:00Z","timestamp":1645142400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Polycystic ovarian syndrome (PCOS) is the most frequent etiology of anovulation, hyperandrogenism and infertility in women. Its pathophysiology remains poorly elucidated. Hyperprolactinemia (hPRL) is common in women of reproductive age\u00a0and may partially mimic the clinical phenotype of PCOS. The simultaneous finding of both conditions is therefore not rare, however there are conflicting studies on whether a link exists between them.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective monocentric study between 2015 and 2021 and among women who were referred for possible PCOS, we selected those who met the ESHRE\/Rotterdam definition criteria. hPRL was defined as two values above the upper limit of normal with at least one measurement in our centre.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 430 women were selected, of whom 179 met the PCOS criteria. 50 out of 179 patients (27.9%) had at least one elevated value of PRL and 21 (11.7%) had hPRL according to our definition. Among the 21 women of the PCOS\/hPRL cohort, 5 (23.8%) had a microprolactinoma and all of them had PRL level \u2265 60 ng\/ml. The remaining cases were macroprolactinemia (n=5), iatrogenic hPRL (n=4), primary hypothyroidism (n=1) or unexplained (n=6) despite exhaustive investigations. The metoclopramide test resulted in an increase of basal PRL &amp;lt; 300% in all prolactinomas and \u2265 300% in all the other etiologies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>hPRL was a common finding in PCOS women, secondary to a microprolactinoma in a quarter of cases. Metoclopramide test performed in women with hPRL below 60 ng\/ml appeared as a helpful tool 1) to discriminate pituitary causes from others etiologies, 2) to potentially avoid unnecessary pituitary MRI.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2022.832361","type":"journal-article","created":{"date-parts":[[2022,2,18]],"date-time":"2022-02-18T04:24:17Z","timestamp":1645158257000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Metoclopramide Test in Hyperprolactinemic Women With Polycystic Ovarian Syndrome: Old Wine Into New Bottles?"],"prefix":"10.3389","volume":"13","author":[{"given":"Claire","family":"Rodier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Blandine","family":"Courbi\u00e8re","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Vermalle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bretelle","family":"Florence","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"No\u00e9mie","family":"Resseguier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thierry","family":"Brue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Cuny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,2,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/J.FERTNSTERT.2016.05.003","article-title":"Criteria, Prevalence, and Phenotypes of Polycystic Ovary Syndrome","volume":"106","author":"Lizneva","year":"2016","journal-title":"Fertil Steril"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1093\/HUMREP\/DEP399","article-title":"The Prevalence of Polycystic Ovary Syndrome in a Community Sample Assessed Under Contrasting Diagnostic Criteria","volume":"25","author":"March","year":"2010","journal-title":"Hum Reprod"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1210\/JC.2009-2724","article-title":"Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women With the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society","volume":"95","author":"Wild","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1111\/CEN.12182","article-title":"Prevalence of Hyperprolactinaemia in Female Premenopausal Blood Donors","volume":"79","author":"Alpa\u00f1\u00e9s","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1210\/JCEM.87.2.8272","article-title":"Macroprolactinemia Revisited: A Study on 106 Patients","volume":"87","author":"Vallette-Kasic","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"B6","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/J.EJOGRB.2014.10.013","article-title":"Importance of Macroprolactinemia in Hyperprolactinemia","volume":"183","author":"Kasum","year":"2014","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1001\/JAMA.2016.19699","article-title":"Diagnosis and Treatment of Pituitary Adenomas: A Review","volume":"317","author":"Molitch","year":"2017","journal-title":"JAMA"},{"key":"B8","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1530\/ACTA.0.1050099","article-title":"Prolactin Secretion in Polycystic Ovary Syndrome (PCO): Correlation With the Steroid Pattern","volume":"105","author":"Carmina","year":"1984","journal-title":"Acta Endocrinol (Copenh)"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1111\/J.1365-2265.1986.TB00759.X","article-title":"Studies of Prolactin Secretion in Polycystic Ovary Syndrome","volume":"24","author":"Murdoch","year":"1986","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1111\/J.1365-2265.2006.02562.X","article-title":"Guidelines of the Pituitary Society for the Diagnosis and Management of Prolactinomas","volume":"65","author":"Casanueva","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2018.05.004","article-title":"Recommendations From the International Evidence-Based Guideline for the Assessment and Management of Polycystic Ovary Syndrome","volume":"110","author":"Teede","year":"2018","journal-title":"Fertil Steril"},{"key":"B12","first-page":"298","article-title":"Polycystic Ovary Syndrome","volume":"29","author":"Dewailly","year":"2000","journal-title":"J Gynecol Obstet Biol Reprod (Paris)"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1080\/09513590.2016.1222363","article-title":"Pituitary Response Profile Following Metoclopramide Administration in Women With Different Forms of Hyperprolactinemia","volume":"33","author":"Espin\u00f3s","year":"2017","journal-title":"Gynecol Endocrinol"},{"key":"B14","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/B978-0-12-823045-9.00012-2","article-title":"Defining PCOS: A Syndrome With An Intrinsic Heterogeneous Nature","volume-title":"Polycystic Ovary Syndrome","author":"Escobar-Morreale","year":"2022"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2016.07.012","article-title":"Prevalence and Predictors of Hyperprolactinemia in Subclinical Hypothyroidism","volume":"35","author":"Sharma","year":"2016","journal-title":"Eur J Intern Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S0889-8545(05)70186-8","article-title":"Polycystic Ovary Syndrome and Hyperprolactinemia","volume":"28","author":"Bracero","year":"2001","journal-title":"Obstet Gynecol Clin North Am"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/J.GYOBFE.2010.11.002","article-title":"Physiopathological Link Between Polycystic Ovary Syndrome and Hyperprolactinemia: Myth or Reality","volume":"39","author":"Robin","year":"2011","journal-title":"Gynecol Obstet Fertil"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1177\/1179558119871921","article-title":"PCOS and Hyperprolactinemia: What do We Know in 2019","volume":"13","author":"Delcour","year":"2019","journal-title":"Clin Med Insights Reprod Heal"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1097\/00006254-199007000-00003","article-title":"Opioid, Catecholamine, and Steroid Interaction in Prolactin and Gonadotropin Regulation","volume":"45","author":"Plosker","year":"1990","journal-title":"Obstet Gynecol Surv"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1073\/PNAS.81.14.4549","article-title":"Direct Arterial Vascularization of Estrogen-Induced Prolactin-Secreting Anterior Pituitary Tumors","volume":"81","author":"Elias","year":"1984","journal-title":"Proc Natl Acad Sci USA"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/AJA.1001280102","article-title":"Local Action of Intrahypophyseal Implants of Estrogen as Revealed by Staining With Peroxidase-Labeled Antibody","volume":"128","author":"Gersten","year":"1970","journal-title":"Am J Anat"},{"key":"B22","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1159\/000094307","article-title":"Genesis of Prolactinomas: Studies Using Estrogen-Treated Animals","volume":"35","author":"Sarkar","year":"2006","journal-title":"Front Horm Res"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(76)90358-6","article-title":"Effects of Large Doses of Estrogen on Prolactin and Growth Hormone Release","volume":"125","author":"Ehara","year":"1976","journal-title":"Am J Obstet Gynecol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1210\/ER.2007-0017","article-title":"What Can We Learn From Rodents About Prolactin in Humans","volume":"29","author":"Ben-Jonathan","year":"2008","journal-title":"Endocr Rev"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/J.ANDO.2007.03.008","article-title":"Prolactinoma and Estrogens: Pregnancy, Contraception and Hormonal Replacement Therapy","volume":"68","author":"Christin-Ma\u00eetre","year":"2007","journal-title":"Ann Endocrinol (Paris)"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1159\/000291850","article-title":"Endocrinological and Clinical Analysis of Hyperprolactinemic Patients With and Without Ultrasonically Diagnosed Polycystic Ovarian Changes","volume":"43","author":"I\u015fik","year":"1997","journal-title":"Gynecol Obstet Invest"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1210\/JCEM-59-4-714","article-title":"Prolactin has a Direct Effect on Adrenal Androgen Secretion","volume":"59","author":"Higuchi","year":"1984","journal-title":"J Clin Endocrinol Metab"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00516","article-title":"Fundamental Concepts and Novel Aspects of Polycystic Ovarian Syndrome: Expert Consensus Resolutions","volume":"11","author":"Aversa","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1002\/CNCR.20412","article-title":"The Prevalence of Pituitary Adenomas: A Systematic Review","volume":"101","author":"Ezzat","year":"2004","journal-title":"Cancer"},{"key":"B30","doi-asserted-by":"publisher","first-page":"e12961","DOI":"10.1111\/ECI.12961","article-title":"The Value of Prolactin in Predicting Prolactinoma in Hyperprolactinaemic Polycystic Ovarian Syndrome","volume":"48","author":"Kyritsi","year":"2018","journal-title":"Eur J Clin Invest"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1210\/JCEM-43-3-679","article-title":"Comparison of Metoclopramide With Other Dynamic Tests of Prolactin Secretion","volume":"43","author":"Sowers","year":"1976","journal-title":"J Clin Endocrinol Metab"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1210\/JCEM-44-5-809","article-title":"Pituitary Autonomy in Hyperprolactinemic Secondary Amenorrhea: Results of Hypothalamic-Pituitary Testing","volume":"44","author":"Healy","year":"1977","journal-title":"J Clin Endocrinol Metab"},{"key":"B33","article-title":"Basal and Metoclopramide Induced Prolactin Secretion in Lean PCOS Women","volume":"40","author":"Mrozinska","year":"2019","journal-title":"Neuroendocr Lett"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2012\/167132","article-title":"Macroprolactinemia: Diagnostic, Clinical, and Pathogenic Significance","volume":"2012","author":"Shimatsu","year":"2012","journal-title":"Clin Dev Immunol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.832361\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,18]],"date-time":"2022-02-18T04:24:22Z","timestamp":1645158262000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.832361\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,18]]},"references-count":34,"alternative-id":["10.3389\/fendo.2022.832361"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2022.832361","relation":{"has-review":[{"id-type":"doi","id":"10.32388\/8HGSYJ","asserted-by":"object"}]},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,18]]},"article-number":"832361"}}